Document is current
Any future updates will be listed below
-
Authors
Ahmed, Hosam F. https://orcid.org/0000-0001-8151-7391
Guzman-Gomez, Amalia https://orcid.org/0000-0003-3419-6462
Desai, Malika https://orcid.org/0000-0003-1873-7409
Dani, Alia https://orcid.org/0000-0003-2493-1603
Morales, David L. S. https://orcid.org/0000-0002-7512-1777
Critser, Paul J.
Zafar, Farhan https://orcid.org/0000-0003-1803-7242
Hayes, Don Jr. https://orcid.org/0000-0002-6734-6052
-
Funding
Funding for this research was provided by:
National Institute of Health (NIH 1R01HL147957-01)
- License Information
-
More Information
Article History
Received: 30 August 2023
Accepted: 13 November 2023
First Online: 26 December 2023
Declarations
:
: Dr. Morales is a consultant for Abbott, Inc., Azyio, Inc., Berlin Heart, Inc., CorMatrix, Inc., Peca, Inc., Syncardia, Inc., and Xeltis, Inc., and serves as a principal investigator for FDA trials sponsored by Peca, Inc. and Xeltis, Inc. Dr Zafar is a procurement surgeon for Transmedics Inc. The rest of authors report no conflicts of interest and have no relevant disclosures regarding this manuscript.
